Clinical Trials Sponsored by Shanghai MicroPort Rhythm MedTech Co., Ltd.

Total 44 results

Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis(CREST)

Coronary Artery Stenosis

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation (CONVOY)

Coronary Artery Perforation

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR)

Coronary Artery Calcification

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Enrolling by invitation

Coronary Atherectomy System in Patients With Coronary Calcification (CORECT)

Calcification of Coronary Artery

China
Shanghai MicroPort EP MedTech Co., Ltd.

Active, not recruiting

A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia (PSVT)

Paroxysmal Supraventricular Tachycardia

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Unknown

VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

Aortic Valve Stenosis

China
Shanghai MicroPort EP MedTech Co., Ltd.

Recruiting

A Dual Energy Catheter (PFA and RFA) and a PFA Catheter for the Treatment of PeAF (PFA，RFA，PeAF)

Persistent Atrial Fibrillation

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Not yet recruiting

VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL） (VITAL)

Aortic Valve Stenosis | Aortic Valve Disease

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Recruiting

VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

Aortic Stenosis

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Recruiting

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Aortic Valve Stenosis

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Not yet recruiting

VitaFlowTM II Transcatheter Aortic Valve System Study

Aortic Valve Stenosis
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) (LARGE-ONE)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Optical Coherence Tomography | Angiography | Intravascular Ultrasound

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

A First-in-Man Study of the Firesorb BVS (FUTURE-I) (FUTURE-I)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

Coronary Artery Disease

Denmark
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease (Firehawk_38)

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

China
Shanghai MicroPort Endovascular MedTech（Group）Co...
Qmed Consulting A/S

Not yet recruiting

CRATOS - Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions

Aortic Dissection Type B | Penetrating Aortic Ulcer | Intramural Hematoma
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's Firesorb BVS: FUTURE-III (FUTURE-III)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (FUTURE-II)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (SAFE-PROTECT)

Stroke | Atrial Fibrillation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear

Rotator Cuff Tears
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

The First-In-Man Pilot Study of Firehawk

Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
OrbusNeich
CCRC Medtech (Shanghai) Co., Ltd.

Recruiting

Scoreflex TRIO - Scoring PTCA Catheter

Coronary Arteriosclerosis

China
Shanghai Golden Leaf MedTec Co. Ltd

Unknown

Renal Denervation for the Treatment of Hypertension: A Pilot Safety and Efficacy Study

Hypertension

China
Shanghai Golden Leaf MedTec Co. Ltd

Active, not recruiting

Endovascular Denervation for the Treatment of Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China
Shanghai Golden Leaf MedTec Co. Ltd

Completed

To Evaluate Safety and Efficacy of a Radiofrequency Renal Denervation System in Treatment of Essential Hypertension

Hypertension

China
Shanghai Golden Leaf MedTec Co. Ltd

Unknown

A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

Stomach Cancer | Bile Duct Cancer | Pancreas Cancer | Liver Cancer
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China
Xijing Hospital
Air Force Military Medical University, China; Chinese Academy of Medical Sciences... and other collaborators

Unknown

Efficacy and Safety of Firebird 2 Stent in Treatment of Complex Coronary Lesions in Diabetes

Coronary Artery Disease

China
Xijing Hospital
Air Force Military Medical University, China; Shanghai MicroPort Medical (Group)... and other collaborators

Unknown

Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions (FIREMAN)

Coronary Disease

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.
The First Affiliated Hospital of Nanchang University; Shanghai Zhongshan Hospital and other collaborators

Recruiting

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions (VITAL)

Chronic Total Occlusion of Coronary Artery

China
Insight Medtech Co., Ltd.
Shanghai Zhongshan Hospital; Guangdong Provincial People's Hospital; Beijing... and other collaborators

Recruiting

Comparison of PFA vs. RFA in Patients With Symptomatic Paroxysmal Atrial Fibrillation.

Arrhythmias, Cardiac | Paroxysmal Atrial Fibrillation

China

Clinical Trials Sponsored by Shanghai MicroPort Rhythm MedTech Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations